Definitive Contract N0017316C2004

This is a $2,102,002.00 cost-plus-fixed-fee definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ibis Biosciences, Inc. for "BIOLOGICAL TECHNOLOGIES OFFICE STUDIES - PHARAOH: SEQUENCE SPECIFIC DNA METHYLATION TO MODULATE GENE EXPRESSION." The contract has an ultimate completion date of September 30, 2017 and was awarded on February 1, 2016. There was no set-aside used for this contract. As this is a DARPA contract, it is likely focused on advanced...

This is a federal contract award to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, valued at $2,343,473.90, was awarded by the Office of Naval Research (ONR) and is for "DIAGNOSTICS TECHNOLOGIES AND TIERED EVALUATION" work. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and has an ultimate completion date of January 2, 2019. The contract does not have a set-aside designation....

<p>This is a federal contract award from the Naval Air Warfare Center (NAVAIR) to Probiusdx Inc., a small business, for a Small Business Innovation Research (SBIR) Phase II research and development project. The contract has a ceiling value of $1,699,050.00 and a performance period ending on April 28, 2023. The contract is a cost-plus-fixed-fee type, and the research is being conducted under the SBIR program. The contract is designated as a Total Small Business set-aside.</p>

This is a Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of point-of-care technologies to monitor and characterize host-pathogen interactions during acute severe infection. The contract has a ceiling value of $147,130.17 and an ultimate completion date of November 24, 2017. The contract is set aside for small...

This is a cost-plus-fixed-fee definitive contract awarded by the Science and Technology Directorate of the Department of Homeland Security to Omni Array Biotechnology LLC, a for-profit limited liability company, for research and development services. The contract has a ceiling value of $199,860.09 and a period of performance ending on September 29, 2016. The contract is not designated as a set-aside. No further details about potential subcontractors or the specific nature of the research and...

This is a firm fixed-price milestone contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Quantitative Biosciences, Inc., a for-profit company based in San Diego, California. The contract is for a study entitled &quot;An Electrical Impedance Platform for Interfacing Synthetic Biology with Microelectronics&quot; and has a ceiling value of $2,724,573.00. The contract is not set aside for any particular business category. The period of performance runs through January 31,...

This is a firm fixed-price delivery order contract awarded by the Joint PEO Chemical and Biological Defense, a defense agency, to Biomeme, Inc., a small disadvantaged business manufacturer of molecular diagnostic solutions. The $2,752,186 contract is for the provision of assay delivery and program management support of the Final Form Configuration System. The contract was not set aside and has a period of performance through July 2016. Biomeme has received other awards from defense agencies such...

This is a $3,214,643.16 firm fixed-price delivery order awarded by the Joint PEO Chemical and Biological Defense, a Defense agency, to Biomeme, Inc., a small disadvantaged business manufacturer of molecular diagnostic solutions. The contract is for the optimization of a FOC (Field of Capability) Threshold Assay Set, with a final completion date of September 15, 2017. Biomeme has provided similar products and services, such as real-time PCR thermocyclers, custom reagents, and assay delivery, to...

This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Applied Biosystems, LLC, a subsidiary of Life Technologies Corporation, for the provision of unspecified products or services related to biomedical research. The contract has an ultimate completion date of April 15, 2012 and a ceiling value of $8,091.79. No set-aside was used for this award. Applied Biosystems, as a manufacturer of scientific instruments, reagents, and...

This is a $749,000.00 firm fixed price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to In Diagnostics, Inc. to develop endpoint and kinetic measurement capabilities on a low-cost, disposable spectrophotometer platform. The contract does not have a set-aside designation and is scheduled for completion by June 30, 2025. The awardee, In Diagnostics, Inc., is a for-profit organization located in Carlsbad, California.